SANUWAVE Health: CEO Frank Morgan C. received 11,286 shares

What happened Frank Morgan C., chief executive officer, received 11,286 derivative shares as an award/grant at $0.00 per share for a total reported value of $0.00 on Sep 30, 2026.

Key details

• Transaction date and price: Sep 30, 2026; $0.00 per share (transaction code A).
• Shares owned after the transaction: the filing does not report shares owned after the transaction.
• Footnotes: F1 states the options were fully vested at the grant date.
• Filing timeliness: the filing does not indicate it was filed late.

Why it may matter

• This was a derivative award (grant of shares/option-related issuance); options were fully vested at grant date per the filing. The filing does not show why the insider traded or why the company acted.